封面
市场调查报告书
商品编码
1528119

基因扩增技术的全球市场

Gene Amplification Technologies

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 293 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球基因扩增技术市场将达101亿美元

预计2023年全球基因扩增技术市场规模为52亿美元,预计2023年至2030年复合年增长率为9.9%,到2030年将达到101亿美元。医疗和製药应用是本报告分析的细分市场之一,预计复合年增长率为 10.9%,到分析期结束时将达到 64 亿美元。分析期间,法证和身分测试应用领域的复合年增长率预计为 8.6%。

美国市场预计将成长27亿美元,中国复合年增长率为12.9%

预计2023年美国基因扩增技术市场规模将达27亿美元。中国作为全球第二大经济体,预计2030年市场规模将达3.859亿美元,2023-2030年分析期间复合年增长率为12.9%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 7.8% 和 9.6%。在欧洲,德国的复合年增长率预计约为 9.2%。

全球基因扩增技术市场 - 主要趋势与驱动因素总结

什么是基因扩增技术?

基因扩增技术是一组用于增加特定 DNA 序列的拷贝数、提高详细分析遗传物质的能力的方法。这些技术在分子生物学、遗传学和临床诊断中至关重要,促进疾病诊断、基因研究和标靶治疗开发的进步。最着名的技术是聚合酵素链锁反应(PCR),它可以将 DNA 序列放大数百万倍,使研究人员能够检查非常小的样本中的遗传物质。即时PCR和数位PCR等创新技术提供定量DNA资料并提高遗传分析的精确度。这些技术快速且准确地扩增基因的能力对于识别致病突变、了解遗传多样性和开发遗传干预措施至关重要。

科技进步如何增强基因扩增的能力

最近的技术进步大大扩展了基因扩增技术的能力和应用。次世代定序(NGS) 整合了基因扩增,可同时对数百万个 DNA 片段进行定序,从而提供对复杂遗传景观的全面洞察。这使得整个基因组能够快速、经济地进行定序,彻底改变了基因组学。此外,基于 CRISPR 的扩增方法的出现为标靶基因编辑和调控提供了新方法,为基因工程和治疗方法开发开闢了新途径。这些最尖端科技不仅使基因分析更加稳健和通用,而且提高了基因研究和诊断的可扩展性和效率。

基因扩增在工业和医学中的新趋势和应用

在个人化医疗和基因工程新趋势的推动下,基因扩增技术的应用正在经历急剧增长。在临床诊断中,这些技术越来越多地用于性行为感染、癌症突变和遗传性疾病的早期检测,以便及时、准确的治疗。在製药业,基因扩增对于药物开发过程至关重要,有助于识别药物标靶并筛检潜在药物的功效和安全性。在农业领域,基因扩增技术也有助于作物改良计划,以确保粮食安全和永续性。此外,环境领域的应用也已开始,基因扩增被用于评估生物多样性和监测各种生态系统中的微生物族群。这些应用凸显了基因扩增技术的多功能性和不可或缺性。

基因扩增技术市场成长的驱动力是什么?

基因扩增技术市场的成长受到多种因素的推动,例如个人化医疗需求的不断增长、全球基因研究资金的增加以及技术的不断进步。遗传疾病和癌症的日益普及促使这些技术在诊断和治疗开发中广泛使用,凸显了它们在现代医学中的作用。此外,扩大生物技术应用和製药业对精准医疗策略的依赖是市场成长的催化剂。消费行为越来越受到有关健康和疾病的遗传见解的影响,这也推动了对基因检测和分析的需求的增加,并推动了基因扩增技术的采用。此外,政府和监管机构正在透过支持性政策、研究经费和奖励来支持这种成长,特别是在基因组计划和健康倡议方面。基因扩增技术,加上确保更高准确性、可及性和成本效益的技术创新,是推动该市场强劲扩张的关键因素。

受访企业举例(共52家)

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Cepheid
  • Enzo Life Sciences, Inc.
  • ELITech Group
  • BioGenex
  • BioCat GmbH
  • Biotecon Diagnostics GmbH
  • Eiken Chemical Co., Ltd.
  • DiaCarta, Inc.
  • Bio-Synthesis Inc.
  • Diatech Pharmacogenetics Srl

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP-1102

Global Gene Amplification Technologies Market to Reach US$10.1 Billion by 2030

The global market for Gene Amplification Technologies estimated at US$5.2 Billion in the year 2023, is expected to reach US$10.1 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Medical & Pharma Application, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Forensic & Identity Testing Application segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 12.9% CAGR

The Gene Amplification Technologies market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$385.9 Million by the year 2030 trailing a CAGR of 12.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Global Gene Amplification Technologies Market - Key Trends & Drivers Summarized

What Are Gene Amplification Technologies and How Are They Transforming Biomedical Research?

Gene amplification technologies constitute a suite of methods used to increase the number of copies of a specific DNA sequence, enhancing the ability to analyze genetic material in detail. These technologies are pivotal in molecular biology, genetics, and clinical diagnostics, facilitating advancements in disease diagnosis, genetic research, and the development of targeted therapies. The most renowned technique, Polymerase Chain Reaction (PCR), amplifies DNA sequences millions of times, enabling researchers to study genetic material from even very small samples. Innovations such as real-time PCR and digital PCR provide quantitative data on DNA, increasing the precision of genetic analysis. The capacity of these technologies to rapidly and accurately amplify genes is critical for identifying disease-causing mutations, understanding genetic diversity, and developing genetic interventions.

How Technological Advancements Enhance the Capabilities of Gene Amplification

Recent technological advancements have significantly expanded the capabilities and applications of gene amplification technologies. Next-Generation Sequencing (NGS) integrates gene amplification to sequence millions of DNA fragments simultaneously, providing comprehensive insights into complex genetic landscapes. This has revolutionized genomics with its ability to decode entire genomes swiftly and more economically than ever before. Additionally, the advent of CRISPR-based amplification methods offers a novel approach to targeted gene editing and regulation, opening new avenues in genetic engineering and therapeutic development. These cutting-edge technologies are not only making gene analysis more robust and versatile but also improving the scalability and efficiency of genetic research and diagnostics.

Emerging Trends and Applications of Gene Amplification in Industry and Medicine

The application of gene amplification technologies is witnessing expansive growth, driven by emerging trends in personalized medicine and genetic engineering. In clinical diagnostics, these technologies are increasingly used for early detection of pathogenic infections, cancer mutations, and genetic disorders, facilitating timely and precise treatment. In the pharmaceutical industry, gene amplification is integral to drug development processes, helping to identify drug targets and screen for potential drug efficacy and safety. The agricultural sector also benefits from these technologies, employing them in crop improvement programs to ensure food security and sustainability. Moreover, environmental applications are emerging, where gene amplification is used to assess biodiversity and monitor microbial populations in various ecosystems. These applications highlight the versatility and indispensability of gene amplification technologies across multiple fields.

What Drives the Growth of the Gene Amplification Technologies Market?

The growth in the gene amplification technologies market is driven by several factors, including the rising demand for personalized medicine, the global increase in genetic research funding, and the continuous advancements in technology. The growing prevalence of genetic disorders and cancer is prompting extensive use of these technologies in diagnostics and therapeutic development, underscoring their role in modern medicine. Furthermore, the expansion of biotechnological applications and the pharmaceutical industry's reliance on precision medicine strategies are catalyzing market growth. Consumer behavior, increasingly informed and influenced by genetic insights into health and disease, also fosters greater demand for genetic testing and analysis, propelling the adoption of gene amplification technologies. Additionally, government and regulatory bodies are bolstering this growth through supportive policies, research funding, and incentives, especially in genomic projects and health initiatives. These factors, combined with technological innovation that ensures higher accuracy, accessibility, and cost-effectiveness, are crucial in driving the robust expansion of this market, making gene amplification technologies fundamental tools in the ongoing exploration and manipulation of genetic material.

Select Competitors (Total 52 Featured) -

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Cepheid
  • Enzo Life Sciences, Inc.
  • ELITech Group
  • BioGenex
  • BioCat GmbH
  • Biotecon Diagnostics GmbH
  • Eiken Chemical Co., Ltd.
  • DiaCarta, Inc.
  • Bio-Synthesis Inc.
  • Diatech Pharmacogenetics Srl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Gene Amplification Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
    • A Prelude to Gene Amplification
    • Gene Amplification Technologies Market Poised to Register Rapid Growth
    • Polymerase Chain Reaction (PCR) - The Most Widely used Gene Amplification Technology
    • US Dominates the Gene Amplification Market
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Number of Genomics Projects Propels Market Growth
    • Genomic Initiatives in Select Countries
    • Advances in Genome Sequencing to Spur the Gene Amplification Market
    • Molecular Diagnostics Progress to Increase Demand for Gene Amplification Technologies
    • Factors Driving Molecular Diagnostics Market
    • Oncology Molecular Diagnostics to Witness Rapid Growth
    • PCR Technology Leads the MDx Market
    • Prospects for Genetic Diagnostics and Testing Grow Brighter
    • List of Select FDA-Cleared Genetic Tests by Disease
    • Increasing Incidence of Infectious Diseases Results in Increased Demand for Gene Amplification Technologies
    • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
    • Emergence of LAMP as Alternative to RT-PCR
    • Advanced DNA Amplification Technique Works at Body Temperature
    • Burgeoning Geriatric Population - A Key Demand Driver for Gene Amplification Technologies
    • Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025
    • Growing Incidence of Hospital Acquired Infections Propels Market Growth
    • Advent of Isothermal DNA Amplification Techniques
    • Isothermal Amplification Method Gaining Traction in Field Applications
    • Loop-Mediated Isothermal Amplification
    • New CRISPR-Based System
    • Gene Amplification Plays Pivotal Role in Diagnosing Inherited Conditions
    • Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
    • PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
    • Increase in Number and Complexity of Foodborne Outbreaks: Food Safety Testing Market Positioned for Growth
    • An Insight into Food Safety Testing Market by Technology
    • Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing
    • Growing Concerns over GMOs Demand Rapid Tests for GMOs Detection
    • Status of Ban on GMO Corps in Select Countries
    • PCR Technique Plays a Vital Role in GMOs Detection
    • Technology Advancements
    • Advanced DNA Amplification Technique Works at Body Temperature
    • Molecular Diagnostics in Water and Food Safety Analysis-Existing Challenges and New Developments
    • Molecular Diagnostics-Future Applications
    • Commercialized Isothermal Amplification Methods for Water and Food Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Gene Amplification Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Gene Amplification Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Medical & Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Medical & Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Medical & Pharma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Forensic & Identity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Forensic & Identity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Forensic & Identity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Agricultural & Food Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Agricultural & Food Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Agricultural & Food Safety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Gene Amplification Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
    • Rising Cancer Cases Spur Growth in Gene Amplification Technology Market
    • Growing Molecular Diagnostics Market Drives the Demand for Gene Amplification Technologies
    • Rapidly Ageing Population: A Major Driving Demand for Gene Amplification Technologies
    • North American Elderly Population by Age Group (1975-2050)
    • Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
    • High Focus on Improving Healthcare Augurs Well for Market Growth
  • JAPAN
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
    • Increasing Need for Geriatric Healthcare and Cancer Care to Drive Demand for Gene Amplification Market
    • Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups
  • CHINA
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
    • Rising Cancer Incidence Drives the Gene Amplification Market
  • EUROPE
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Gene Amplification Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Gene Amplification Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
    • Rising Cancer Incidence Drives the European Gene Amplification Market
  • FRANCE
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Gene Amplification Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030
    • Growing Incidence of Cancer in Asia-Pacific to Propel the Demand for Gene Amplification Market
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of World 16-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION